中西医结合中药治疗降低多囊卵巢综合征患者2型糖尿病风险:全国匹配队列研究
平均随访5.2年(对照组4.20年),中药组2型糖尿病(T2DM)发生率显著低于非中药组(HR=0.31;95%CI 0.15-0.64;P=0.0014)。五种复方和两种单味药显示保护效应,白芍为五种复方的共同成分。
要点
- 中药干预与PCOS患者T2DM风险显著降低相关(HR=0.31)。
- 五种复方和两种单味药显示保护效应,白芍为共同成分。
- 结果为观察性证据,需进一步临床与药理研究验证。
核心结论
- 中药治疗可能有助于预防PCOS患者发生T2DM相关并发症。
主要发现
- 平均随访5.2年(对照组4.20年),中药组T2DM发生率显著低于非中药组(HR=0.31;95%CI 0.15-0.64;P=0.0014)。
- 五种复方和两种单味药显示保护效应,白芍为五种复方的共同成分。
临床怎么用
- 对PCOS患者,可考虑在辨证论治基础上结合中药干预以降低T2DM风险,但需结合个体情况并告知证据局限性。
局限性
- 本研究为回顾性观察性研究,可能存在未测量的混杂因素,因果关系需进一步临床试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Polycystic ovary syndrome (PCOS) is a common condition that affects 5%-10% of women of reproductive age worldwide. Patients with PCOS have a high degree of insulin resistance and are at an increased risk of developing type 2 diabetes mellitus (T2DM). The currently available therapeutic approaches for PCOS mainly focus on symptomatic treatment. AIM OF THE STUDY: This study aimed to determine whether Chinese herbal medicine (CMH)-based interventions could reduce the risk of T2DM in PCOS patients. MATERIALS AND METHODS: This retrospective study randomly selected 1 million enrollees from the National Health Insurance Database and identified 3797 patients who were newly diagnosed with PCOS in 1997-2010. After 1:1 frequency-matched by age, diagnosis of PCOS year and index days, we selected 342 eligible patients in each group. RESULTS: The incidence of T2DM in the CHM group was significantly lower than that in the non-CHM group (hazard ratio = 0.31; 95% confidence interval, 0.15-0.64; p = 0.0014) after a mean follow-up period of 5.2 years (4.20 years for the comparison cohort). Five herbal formulas and two single herbs showed protective effects, and Paeonia lactiflora was a common ingredient in the five formulas. CONCLUSIONS: Thus, CHM may help prevent T2DM-related complications in patients with PCOS. Further clinical and pharmacological analysis based on these findings is expected in the future.
引用
- Liao WT, Su CC, Lee MT, et al. Integrative Chinese herbal medicine therapy reduced the risk of type 2 diabetes mellitus in patients with polycystic ovary syndrome: A nationwide matched cohort study. J Ethnopharmacol. 2019. PMID: 31325604. doi:10.1016/j.jep.2019.112091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。